Co-founder Receives 40 Under 40 Award

Massive Bio’s Co-Founder and Chief Medical Advisor Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP has been selected as a recipient of the 40 Under 40 in Cancer Award for his contributions to the field of cancer. The award recognizes promising leaders under the age of 40 that are improving the lives of cancer patients, caregivers, oncologists, and all those affected by cancer.

Along with his involvement with Massive Bio, Dr. Loaiza-Bonilla is the current Vice Chairman of the Department of Medical Oncology at Cancer Treatment Centers of America (CTCA), Chief of Medical Oncology and Medical Director of Research at CTCA – Philadelphia, and was recently named the President of Pennsylvania Society of Oncology & Hematology. With his experience working at the Abramson Cancer Center of the University of Pennsylvania, University of Miami, Johns Hopkins, and the National Institutes of Health, he is an expert in precision oncology whose work has been published in ASCO’s Clinical Journal of Oncology and Google Scholar. Massive Bio is proud to have Dr. Loaiza-Bonilla on the team to work towards creating positive outcomes for cancer patients.

A virtual celebration of the 40 Under 40 Award will take place Thursday, October 15 at 6:30 pm EST.

Learn more about Dr. Loaiza-Bonilla’s New Presidency of the Pennsylvania Society of Oncology & Hematology here.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial
See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.